Lupkynis (voclosporin) - Aurinia Pharma
Current Use of Physiologically-Based Pharmacokinetic (PBPK) Modeling in New Medicinal Product Approvals at EMA: A Clinical Appraisal of Voclosporin in Lupus Nephritis. (PubMed, Clin Pharmacol Ther) - May 29, 2025 - No abstract available 
European regulatory • Journal • PK/PD data • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
http://www.ncbi.nlm.nih.gov/pubmed/40438906
 
Dirk R J Kuypers
 
May 29, 2025
 
Prev Next